RMD vs TGTX · P/E 29, rev $5.65B vs P/E 18, rev $240.3M
ResMed Inc (RMD) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the RMD and TGTX stock pages for the full models.
Not investment advice.